Trial · NCT00965757
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double-blind Phase | STARTED | T-614 (Double-blind, 1-28 Weeks) | 165 | |
| Double-blind Phase | STARTED | Placebo (Double-blind, 1-28 Weeks) | 88 | |
| Double-blind Phase | STARTED | T-614 (Extension, 29-52 Weeks) | 0 | |
| Double-blind Phase | STARTED | Placebo/T-614 (Extension, 29-52 Weeks) | 0 | |
| Double-blind Phase | COMPLETED | T-614 (Double-blind, 1-28 Weeks) | 148 | |
| Double-blind Phase | COMPLETED | Placebo (Double-blind, 1-28 Weeks) | 70 | |
| Double-blind Phase | COMPLETED | T-614 (Extension, 29-52 Weeks) | 0 | |
| Double-blind Phase | COMPLETED | Placebo/T-614 (Extension, 29-52 Weeks) | 0 | |
| Double-blind Phase | NOT COMPLETED | T-614 (Double-blind, 1-28 Weeks) | 17 | |
| Double-blind Phase | NOT COMPLETED | Placebo (Double-blind, 1-28 Weeks) | 18 | |
| Double-blind Phase | NOT COMPLETED | T-614 (Extension, 29-52 Weeks) | 0 | |
| Double-blind Phase | NOT COMPLETED | Placebo/T-614 (Extension, 29-52 Weeks) | 0 | |
| Extension Phase | STARTED | T-614 (Double-blind, 1-28 Weeks) | 0 | |
| Extension Phase | STARTED | Placebo (Double-blind, 1-28 Weeks) | 0 | |
| Extension Phase | STARTED | T-614 (Extension, 29-52 Weeks) | 165 | |
| Extension Phase | STARTED | Placebo/T-614 (Extension, 29-52 Weeks) | 88 | |
| Extension Phase | COMPLETED | T-614 (Double-blind, 1-28 Weeks) | 0 | |
| Extension Phase | COMPLETED | Placebo (Double-blind, 1-28 Weeks) | 0 | |
| Extension Phase | COMPLETED | T-614 (Extension, 29-52 Weeks) | 132 | |
| Extension Phase | COMPLETED | Placebo/T-614 (Extension, 29-52 Weeks) | 64 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00965757/flow